% Expired Patents = 75.0

Forward Citations = 66

Loading Chart...

4 inventors (with patents filed for the assignee):

Dirk Vetter (4 out of 21 patents)

Kristina Schmidt (4 out of 9 patents)

Stefan Dickopf (3 out of 5 patents)

4. Klaus Burkert (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6921514 - Device for carrying out an almost simultaneous synthesis of a plurality of samples (2005-07-26),

2. 6795192 - SPR sensor and SPR sensor array (2004-09-21),

3. 6752963 - SPR sensor system (2004-06-22),

4. 6441906 - Set-up of measuring instruments for the parallel readout of SPR sensors (2002-08-27),

Company Overview

Graffinity Pharmaceutical Design GmbH is a leading drug discovery company that specializes in fragment-based drug design. With cutting-edge technology and a team of experienced scientists, Graffinity helps pharmaceutical companies accelerate the drug discovery process and bring new treatments to market efficiently. Their innovative approach has led to successful collaborations with leading biotech and pharmaceutical companies worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#65 in Heidelberg

#7,035 in Germany

Heidelberg, Germany

Graffinity Pharmaceutical Design Gmbh

Forward Citations = 66

4 inventors:

Dirk Vetter (4 out of 21 patents)

Kristina Schmidt (4 out of 9 patents)

Stefan Dickopf (3 out of 5 patents)

4. Klaus Burkert (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Graffinity Pharmaceutical Design Gmbh. Retrieved from https://idiyas.com/company/graffinity-pharmaceutical-design

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]